WHO - IMSDA

India Pharma Knowledge Roundup June 2026: Women’s Health, Semaglutide Boom and Quality Reform

Post published:June 22, 2026
Post category:Knowledge

June 2026 marks a pivotal moment for India's generic pharmaceutical industry. From landmark shifts toward women's health therapeutics to explosive growth in the generic GLP-1 market and sweeping drug-quality reforms,…

Understanding Bioequivalence: Why Indian Generic Medicines Work as Well as Branded Drugs

Post published:June 22, 2026
Post category:Knowledge

One of the most common questions international buyers ask about Indian generic medicines is: "Are they really as effective as the original branded drug?" The answer lies in a rigorous…

Indian Pharma’s Strategic Pivot from Generics to Specialty Drugs and Biosimilars

Post published:June 21, 2026
Post category:News

Indian pharmaceutical companies, long celebrated as the “pharmacy of the world” for their affordable generic medicines, are now charting a strategic course toward specialty drugs, biosimilars, and innovative therapies. This…

How to Safely Import Generic Medicines from India: A 2026 Buyer’s Guide

Post published:June 17, 2026
Post category:Knowledge

How to Safely Import Generic Medicines from India: A 2026 Buyer's Guide India supplies over 20% of the world's generic medicines by volume and 60% of global vaccine demand. For…